SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Rodgers, R.J.
Right arrow Articles by Cole, J.C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Rodgers, R.J.
Right arrow Articles by Cole, J.C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Effects of ritanserin and 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) in the murine elevated plus-maze test of anxiety: an ethopharmacological study

R.J. Rodgers

Ethopharmacology Laboratory, Department of Psychology, University of Leeds, Leeds LS2 9JT, UK

N.J.T. Johnson

Ethopharmacology Laboratory, Department of Psychology, University of Leeds, Leeds LS2 9JT, UK

S.J. Norton

Ethopharmacology Laboratory, Department of Psychology, University of Leeds, Leeds LS2 9JT, UK

J.C. Cole

Ethopharmacology Laboratory, Department of Psychology, University of Leeds, Leeds LS2 9JT, UK

The 5-HT2A/2c receptor antagonist, ritanserin, has produced highly variable results in animal models of anxiety. The present study addressed the effects of this compound (0.5-5.0 mg/kg) and those of the 5-HT2A/2C receptor agonist, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (0.25-1.0 mg/kg), in an ethological version of the murine elevated plus-maze paradigm. In marked contrast to the potent effects produced by other compounds (anxiolytic and anxiogenic) under identical test conditions, results show that, over the dose ranges tested, neither compound significantly altered behavioural profiles. Findings are discussed in relation to the question of receptor affinities and the need for studies on compounds with more selective profiles of action.

Key Words: elevated plus-maze • anxiety • defence • risk assessment • ritanserin • DOI • 5-HT • mice

Journal of Psychopharmacology, Vol. 9, No. 1, 38-42 (1995)
DOI: 10.1177/026988119500900107


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement